{
    "clinical_study": {
        "@rank": "159908", 
        "arm_group": [
            {
                "arm_group_label": "Docetaxel & Oxaliplatin & Capecitabine", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive cycles every 3 weeks of Docetaxel (35 mg/ m2, intravenous at days 1 and 8 by 1-hour infusion)and Oxaliplatin (80 mg/ m2, intravenous at day 1 by 2-hour infusion) and Capecitabine (750 mg/ m2, oral tablets of 500 and 150 mg, x2 daily for 2 weeks)"
            }, 
            {
                "arm_group_label": "Epirubicin & Oxaliplatin & Capecitabine", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive cycles every 3 weeks of Epirubicin (50 mg/ m2, intravenous on day 1 by 2-hour infusion)and Oxaliplatin (130 mg/ m2, intravenous on day 1 by 2-hour infusion) and Capecitabine (625 mg/ m2,oral tablets of 500 and 150 mg, x2 daily for 3 weeks)"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized, parallel group, non-blinded phase III trial. Patients with advanced\n      (locoregional or metastatic) gastric cancer not previously treated with chemotherapy for\n      this stage will be randomized in a 1:1 ratio to receive low-TOX (arm A) or EOX (arm B).\n      Randomization will be stratified by performance status (ECOG 0 or 1)."
        }, 
        "brief_title": "Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Locally Advanced Unresectable Gastric Cancer", 
            "Metastatic Gastric Cancer"
        ], 
        "condition_browse": {
            "mesh_term": "Stomach Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Although the incidence of the adenocarcinoma of the stomach is slowly decreasing, gastric\n      cancer represents the second worldwide cause of cancer death after lung cancer. In patients\n      with advanced disease, chemotherapy improves survival and quality of life. Combinations of\n      two or three drugs including a platin derivative (cisplatin or oxaliplatin), a\n      fluoropyrimidine (5FU or capecitabine) and an anthracycline (usually epirubicin) have\n      demonstrated superiority compared to single or double agent therapy and are the current\n      standard. As of today there are no published studies comparing anthracycline-based to\n      taxane-based three-drug regimens. The objective of the present study is to compare EOX as\n      evaluated in REAL-2 to the low-TOX regimen consisting of docetaxel, oxaliplatin and\n      capecitabine. Low-TOX is expected to be better tolerated than the original DCF regimen. The\n      study will be performed in the HER2 negative patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed written informed consent prior to beginning protocol specific procedures\n\n          -  Male or female <70 years of age\n\n          -  Histologically proven diagnosis of adenocarcinoma of the stomach\n\n          -  HER2 negative tumor or HER2+ tumors not qualifying for herceptin therapy\n\n          -  Locally advanced (non resectable) or metastatic gastric cancer\n\n          -  Presence of measurable disease with at least one measurable lesion by means   of CT\n             scan or MRI in not previously irradiated area(s) (according to RECIST criteria\n             (version 1.1)\n\n          -  Life expectancy of >/= 3 months\n\n          -  ECOG performance status of 0-1 at study entry\n\n          -  Neutrophils >/= 2.0 x 1000000000/L, platelets >/= 100 x 1000000000/L, and hemoglobin\n             >/= 10 g/dL\n\n          -  Bilirubin level either normal or </= 1.5 x ULN\n\n          -  AST and ALT </= 2.5 X UNL (</= 5 x ULN if liver metastasis are present\n\n          -  Alkaline phosphatase (ALP) </= 2.5 X ULN; patients with alkaline phosphatase > 2.5x\n             ULN and AST and ALT </= 1.5 x ULN are equally eligible\n\n          -  Serum creatinine < 1.5 x ULN. In presence border-line values, the calculated\n             creatinine clearance should be >/= 60 mL/min\n\n          -  Negative pregnancy test (if female in reproductive years)\n\n          -  Effective contraception prior to study entry and for the duration of the study\n             participation, for both male and female patients of child producing potential\n\n          -  Able and willing to comply with scheduled visits, therapy plans and laboratory tests\n             required in this protocol\n\n        Exclusion Criteria:\n\n          -  Previous chemotherapy, except adjuvant treatment administered at least 1 year before\n             study entry\n\n          -  Concurrent chronic systemic immune therapy\n\n          -  Any investigational agent(s) 4 weeks prior to entry\n\n          -  Clinically relevant coronary artery disease or a history of a myocardial infarction\n             or a history of hypertension not controlled by therapy within the last 12 months\n\n          -  Known hypersensitivity to study drugs. Known grade 3 or 4 allergic reaction to any of\n             the components of the treatment\n\n          -  Known drug abuse/ alcohol abuse\n\n          -  Acute or subacute intestinal occlusion and any other significant chronic\n             gastrointestinal disease that might interfere with absorption of oral treatment\n\n          -  History of clinically relevant psychiatric disability precluding informed consent\n\n          -  Presence of any psychological, familial, sociological or geographical condition\n             potentially hampering compliance with the study protocol and follow-up schedule\n\n          -  Pregnant or breastfeeding women\n\n          -  Active uncontrolled infection(s)\n\n          -  Positive for HIV serology and/or viral hepatitis B or C\n\n          -  Any concurrent malignancy other than non-melanoma skin cancer, or carcinoma in situ\n             of the cervix. (Patients with a previous malignancy but without evidence of disease\n             for \u2265 5 years will be allowed to enter the trial)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "462", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076594", 
            "org_study_id": "LEGA", 
            "secondary_id": "2011-005537-39"
        }, 
        "intervention": [
            {
                "arm_group_label": "Docetaxel & Oxaliplatin & Capecitabine", 
                "description": "Powder for solution for infusion", 
                "intervention_name": "Docetaxel", 
                "intervention_type": "Drug", 
                "other_name": "Taxotere 20 mg/mL"
            }, 
            {
                "arm_group_label": "Epirubicin & Oxaliplatin & Capecitabine", 
                "description": "Solution for infusion", 
                "intervention_name": "Epirubicin", 
                "intervention_type": "Drug", 
                "other_name": "Farmorubicina 2mg/mL"
            }, 
            {
                "arm_group_label": [
                    "Docetaxel & Oxaliplatin & Capecitabine", 
                    "Epirubicin & Oxaliplatin & Capecitabine"
                ], 
                "description": "Powder for solution for infusion", 
                "intervention_name": "Oxaliplatin", 
                "intervention_type": "Drug", 
                "other_name": "Eloxatin 5 mg/mL"
            }, 
            {
                "arm_group_label": [
                    "Docetaxel & Oxaliplatin & Capecitabine", 
                    "Epirubicin & Oxaliplatin & Capecitabine"
                ], 
                "description": "Film coated tablets", 
                "intervention_name": "Capecitabine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Xeloda 150 mg", 
                    "Xeloda 500 mg"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epirubicin", 
                "Oxaliplatin", 
                "Docetaxel", 
                "Capecitabine", 
                "Fluorouracil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 26, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Rosa Rita Silva, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Fabriano", 
                        "country": "Italy", 
                        "state": "AN", 
                        "zip": "60044"
                    }, 
                    "name": "ASUR Zona territoriale 6 di Fabriano (AN)"
                }, 
                "investigator": {
                    "last_name": "Rosa Rita Silva, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "n.silvestris@oncologico.bari.it", 
                    "last_name": "Nicola Silvestris, MD", 
                    "phone": "+39 080 5555419"
                }, 
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy", 
                        "state": "BA", 
                        "zip": "70124"
                    }, 
                    "name": "Istituto Tumori"
                }, 
                "investigator": {
                    "last_name": "Nicola Silvestris, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rlabianca@hpg23.it", 
                    "last_name": "Roberto Labianca, MD", 
                    "phone": "+39 035 2673691"
                }, 
                "facility": {
                    "address": {
                        "city": "Bergamo", 
                        "country": "Italy", 
                        "state": "BG", 
                        "zip": "24127"
                    }, 
                    "name": "Azienda Ospedaliera Papa Giovanni XXIII"
                }, 
                "investigator": {
                    "last_name": "Roberto Labianca, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pietro Sozzi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Biella", 
                        "country": "Italy", 
                        "state": "BI", 
                        "zip": "13900"
                    }, 
                    "name": "Ospedale degli Infermi"
                }, 
                "investigator": {
                    "last_name": "Pietro Sozzi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Claudio Graiff, MD", 
                    "phone": "+39 0471 908952"
                }, 
                "facility": {
                    "address": {
                        "city": "Bolzano", 
                        "country": "Italy", 
                        "state": "BZ", 
                        "zip": "39100"
                    }, 
                    "name": "ASDAA Bolzano"
                }, 
                "investigator": {
                    "last_name": "Claudio Graiff, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Monica Giordano, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Como", 
                        "country": "Italy", 
                        "state": "CO", 
                        "zip": "22020"
                    }, 
                    "name": "Azienda Ospedaliera Sant'Anna"
                }, 
                "investigator": {
                    "last_name": "Monica Giordano, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Stefania Dell'Oro, MD", 
                    "phone": "+39 0341 489155"
                }, 
                "facility": {
                    "address": {
                        "city": "Lecco", 
                        "country": "Italy", 
                        "state": "LC", 
                        "zip": "23900"
                    }, 
                    "name": "Ospedale di Circolo A. Manzoni"
                }, 
                "investigator": {
                    "last_name": "Stefania Dell'Oro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Ucci, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lodi", 
                        "country": "Italy", 
                        "state": "LO", 
                        "zip": "26900"
                    }, 
                    "name": "Azienda Ospedaliera Ospedale Maggiore"
                }, 
                "investigator": {
                    "last_name": "Giovanni Ucci, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Domenico Amoroso, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Camaiore", 
                        "country": "Italy", 
                        "state": "LU", 
                        "zip": "55041"
                    }, 
                    "name": "A.O. Ospedale Versilia"
                }, 
                "investigator": {
                    "last_name": "Domenico Amoroso, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marina Cazzaniga, MD", 
                    "phone": "+39 039 2339575"
                }, 
                "facility": {
                    "address": {
                        "city": "Monza", 
                        "country": "Italy", 
                        "state": "MB", 
                        "zip": "20900"
                    }, 
                    "name": "Azienda Ospedaliera San Gerardo di Monza,"
                }, 
                "investigator": {
                    "last_name": "Marina Cazzaniga, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "maurizio.tomirotti@policlinico.mi.it", 
                    "last_name": "Maurizio Tomirotti, MD", 
                    "phone": "+39 02 55032783"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20122"
                    }, 
                    "name": "Fondazione IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico"
                }, 
                "investigator": {
                    "last_name": "Maurizio Tomirotti, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicola Fazio, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20141"
                    }, 
                    "name": "IRCCS Istituto Europeo di Oncologia (IEO)"
                }, 
                "investigator": {
                    "last_name": "Nicola Fazio, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Daris Ferrari, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20142"
                    }, 
                    "name": "Azienda Ospedaliera San Paolo"
                }, 
                "investigator": {
                    "last_name": "Daris Ferrari, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Elena Piazza, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20157"
                    }, 
                    "name": "Ospedale L. Sacco"
                }, 
                "investigator": {
                    "last_name": "Elena Piazza, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "maria.dibartolomeo@istitutotumori.mi.it", 
                    "last_name": "Maria Di Bartolomeo, MD", 
                    "phone": "+39 02 23902882"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20133"
                    }, 
                    "name": "Fondazione IRCCS Istituto Nazionale dei Tumori"
                }, 
                "investigator": {
                    "last_name": "Maria Di Bartolomeo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabrizio Artioli, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Carpi", 
                        "country": "Italy", 
                        "state": "MO", 
                        "zip": "41012"
                    }, 
                    "name": "Ospedale di Carpi"
                }, 
                "investigator": {
                    "last_name": "Fabrizio Artioli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "l.cavanna@ausl.pc.it", 
                    "last_name": "Luigi Cavanna, MD", 
                    "phone": "+39 0523 302697"
                }, 
                "facility": {
                    "address": {
                        "city": "Piacenza", 
                        "country": "Italy", 
                        "state": "PC", 
                        "zip": "29100"
                    }, 
                    "name": "AUSL di Piacenza"
                }, 
                "investigator": {
                    "last_name": "Luigi Cavanna, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Donato Natale, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Penne", 
                        "country": "Italy", 
                        "state": "PE", 
                        "zip": "65017"
                    }, 
                    "name": "ASL Pescara Ospedale San Massimo"
                }, 
                "investigator": {
                    "last_name": "Donato Natale, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Vincenzo Catalano, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Pesaro", 
                        "country": "Italy", 
                        "state": "PE", 
                        "zip": "61122"
                    }, 
                    "name": "A.O. Ospedali Riuniti Marche Nord - Presidio S. Salvatore Muraglia"
                }, 
                "investigator": {
                    "last_name": "Vincenzo Catalano, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marco Lombardo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Pescara", 
                        "country": "Italy", 
                        "state": "PE", 
                        "zip": "65124"
                    }, 
                    "name": "Ospedale Civile Spirito Santo"
                }, 
                "investigator": {
                    "last_name": "Marco Lombardo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrea Ciarlo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Prato", 
                        "country": "Italy", 
                        "state": "PO", 
                        "zip": "59100"
                    }, 
                    "name": "Ospedale Misericordia e Dolce"
                }, 
                "investigator": {
                    "last_name": "Andrea Ciarlo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Domenico Bilancia, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Potenza", 
                        "country": "Italy", 
                        "state": "PZ", 
                        "zip": "85100"
                    }, 
                    "name": "Azienda Ospedaliera Ospedale San Carlo"
                }, 
                "investigator": {
                    "last_name": "Domenico Bilancia, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Corrado Boni, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Reggio Emilia", 
                        "country": "Italy", 
                        "state": "RE", 
                        "zip": "42100"
                    }, 
                    "name": "Ospedale di S. Maria Nuova"
                }, 
                "investigator": {
                    "last_name": "Corrado Boni, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Enrico Cortesi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "RM", 
                        "zip": "00161"
                    }, 
                    "name": "Azienda Policlinico Umberto I"
                }, 
                "investigator": {
                    "last_name": "Enrico Cortesi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Domenico Cristiano Corsi, MD", 
                    "phone": "+39 06 6837249"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "RM", 
                        "zip": "00186"
                    }, 
                    "name": "Ospedale Fatebenefratelli"
                }, 
                "investigator": {
                    "last_name": "Domenico Cristiano Corsi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alessandro Bertolini, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sondrio", 
                        "country": "Italy", 
                        "state": "SO", 
                        "zip": "23100"
                    }, 
                    "name": "Azienda Ospedaliera Valtellina e Valchiavenna - Ospedale Civile"
                }, 
                "investigator": {
                    "last_name": "Alessandro Bertolini, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Libero Ciuffreda, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "state": "TO", 
                        "zip": "10126"
                    }, 
                    "name": "Azienda Ospedaliera Citt\u00e0 della Salute e della Scienza di Torino"
                }, 
                "investigator": {
                    "last_name": "Libero Ciuffreda, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Claudio Verusio, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Saronno", 
                        "country": "Italy", 
                        "state": "VA", 
                        "zip": "21047"
                    }, 
                    "name": "Ospedale Generale Provinciale di Saronno"
                }, 
                "investigator": {
                    "last_name": "Claudio Verusio, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Graziella Pinotti, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "state": "VA", 
                        "zip": "21100"
                    }, 
                    "name": "Ospedale di Circolo e Fondazione Macchi di Varese"
                }, 
                "investigator": {
                    "last_name": "Graziella Pinotti, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Massimo Cirillo, MD", 
                    "phone": "+39 0456013472"
                }, 
                "facility": {
                    "address": {
                        "city": "Negrar", 
                        "country": "Italy", 
                        "state": "VR", 
                        "zip": "37024"
                    }, 
                    "name": "Ospedale Sacro Cuore Don Calabria di Negrar"
                }, 
                "investigator": {
                    "last_name": "Massimo Cirillo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Rosario Vincenzo , Iaffaioli"
                }, 
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy", 
                        "zip": "80131"
                    }, 
                    "name": "IRCCS Istituto Nazionale Tumori Fondazione Pascale"
                }, 
                "investigator": {
                    "last_name": "Rosario Vincenzo Iaffaioli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer", 
        "overall_contact": {
            "email": "rlabianca@hpg23.it", 
            "last_name": "Roberto Labianca, MD", 
            "phone": "+39 035 2673691"
        }, 
        "overall_official": [
            {
                "affiliation": "A.O. Papa Giovanni XXIII  di Bergamo, Oncologia Medica", 
                "last_name": "Roberto Labianca, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "A.O. San Gerardo di Monza, Oncologia Medica", 
                "last_name": "Marina Cazzaniga, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Policlinico Umbero I di Roma, UOC Oncologia Medica B", 
                "last_name": "Enrico Cortesi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Fatebenefratelli di Roma, Oncologia", 
                "last_name": "Domenico Cristiano Corsi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale degli Infermi di Biella, Oncologia", 
                "last_name": "Pietro Sozzi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AUSL di Piacenza, Oncologia Medica", 
                "last_name": "Luigi Cavanna, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A.O.  Ospedale San Carlo di Potenza, Oncologia Medica", 
                "last_name": "Domenico Bilancia, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "ASUR Zona 6 di Fabriano, Oncologia", 
                "last_name": "Rosa Rita Silva, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "IRCCS Istituto Europeo di Oncologia di Milano, Tumori digestivi superiori e Neuroendocrini", 
                "last_name": "Nicola Fazio, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A. O. Sant'Anna di Como, Oncologia", 
                "last_name": "Monica Giordano, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Civile di Sondrio,  Oncologia Medica", 
                "last_name": "Alessandro Bertolini, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A.O. Ospedale Maggiore di Lodi, Oncologia", 
                "last_name": "Giovanni Ucci, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Civile San Massimo di Penne, Oncologia", 
                "last_name": "Donato Natale, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A.O. San Paolo di Milano, Oncologia Medica", 
                "last_name": "Daris Ferrari, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale di Circolo e Fondazione Macchi di Varese,  Oncologia", 
                "last_name": "Graziella Pinotti, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale di S. Maria Nuova di Reggio Emilia, Oncologia Medica", 
                "last_name": "Corrado Boni, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Sacro Cuore Don Calabria di Negrar,  Oncologia Medica", 
                "last_name": "Massimo Cirillo, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "IRCCS Istituto Nazionale Tumori Fondazione Pascale di Napoli, Oncologia Medica Addominale", 
                "last_name": "Rosario Vincenzo Iaffaioli, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Misericordia e Dolce di Prato, Oncologia Medica", 
                "last_name": "Andrea Ciarlo, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Civile Spirito Santo di Pescara, Oncologia Medica", 
                "last_name": "Marco Lombardo, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale L. Sacco di Milano, Oncologia", 
                "last_name": "Elena Piazza, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Azienda Ospedaliera Citt\u00e0 della Salute e della Scienza di Torino, Oncologia Medica", 
                "last_name": "Libero Ciuffreda, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale di Circolo A. Manzoni di Lecco, Oncologia Medica", 
                "last_name": "Stefania Dell'Oro, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale di Carpi, Medicina Oncologica", 
                "last_name": "Fabrizio Artioli, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Generale Provinciale di Saronno, Oncologia Medica", 
                "last_name": "Claudio Verusio, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A.O. Ospedali Riuniti Marche Nord - Presidio S. Salvatore Muraglia, Oncologia", 
                "last_name": "Vincenzo Catalano, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "ASDAA Bolzano, Oncologia Medica", 
                "last_name": "Claudio Graiff, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "A.O. Ospedale Versilia di Camaiore, Oncologia Medica", 
                "last_name": "Domenico Amoroso, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Medicina Oncologica 1", 
                "last_name": "Maria Di Bartolomeo, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Istituto Tumori di Bari, Oncologia Medica", 
                "last_name": "Nicola Silvestris, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fondazione IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico di Milano, Oncologia Medica", 
                "last_name": "Maurizio Tomirotti, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: The Italian Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess overall survival (OS) of patients with locally advanced unresectable or metastatic gastric cancer treated with Docetaxel plus Oxaliplatin plus Capecitabine (Arm A) or with Epirubicin plus Oxaliplatin plus Capecitabine (Arm B)", 
            "measure": "Overall Survival (OS)", 
            "safety_issue": "No", 
            "time_frame": "Measured as the time from randomization to the date of death from any cause, assessed up to 18 months of follow up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076594"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To determine the progression free survival of patients with locally advanced unresectable or metastatic gastric cancer treated with Docetaxel plus Oxaliplatin plus Capecitabine (Arm A) or with Epirubicin plus Oxaliplatin plus Capecitabine (Arm B)", 
                "measure": "Progression Free Survival (PFS)", 
                "safety_issue": "No", 
                "time_frame": "Measured as the time from randomization to the date of local or regional progression, distant metastasis, second primary malignancy or death from any cause, whichever comes first,  assessed up to 18 months of follow up"
            }, 
            {
                "description": "To assess objective response rate (CR+PR)of patients with locally advanced unresectable or metastatic gastric cancer treated with Docetaxel plus Oxaliplatin plus Capecitabine (Arm A) or with Epirubicin plus Oxaliplatin plus Capecitabine (Arm B)", 
                "measure": "Objective Response Rate (CR + PR) according to RECIST 1.1 guideline", 
                "safety_issue": "No", 
                "time_frame": "Measured as the time from randomization, assessed up to 18 months of follow up"
            }, 
            {
                "description": "To assess disease control rate of patients with locally advanced unresectable or metastatic gastric cancer treated with Docetaxel plus Oxaliplatin plus Capecitabine (Arm A) or with Epirubicin plus Oxaliplatin plus Capecitabine (Arm B)", 
                "measure": "Disease control rate: CR + PR + SD lasting > 12 weeks", 
                "safety_issue": "No", 
                "time_frame": "Measured as the time from randomization, assessed up to 18 months of follow up"
            }, 
            {
                "description": "To assess tolerability of the treatments of patients with locally advanced unresectable or metastatic gastric cancer treated with Docetaxel plus Oxaliplatin plus Capecitabine (Arm A) or with Epirubicin plus Oxaliplatin plus Capecitabine (Arm B)", 
                "measure": "Tolerability of the treatments evaluated in term of occurrence of: side effects graded according to the NCI-CTCAE scale (version 4.0); serious adverse reactions, expected and unexpected", 
                "safety_issue": "Yes", 
                "time_frame": "Measured as the time from randomization, assessed up to 18 months of follow up"
            }
        ], 
        "source": "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente", 
        "sponsors": {
            "collaborator": {
                "agency": "Regione Lombardia", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}